HAPPEL DAVID (President & CEO) purchased 1.9% of their position (12.10K shares) of SAGIMET BIOSCIENCES INC. on the open market
Open‑market purchase worth $63.7K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/28/2024ACC: 0001104659-24-040517
DirectorOfficer· President & CEO
Since Feb 2026
+12.10K
Net shares
Net buyer
$63.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
12.10K acquired
Non-Derivative Transactions1
Series A Common Stock
Direct
Shares
+12.10K
Price / share
$5.27
Trade value
$63.73K
% of position
1.9%
3/26/2024
627.10K→639.20K
Total
Net shares
+12.10K
Net value
$63.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series A Common Stock Direct | 3/26/2024 | P · Purchase | +12.10K | $5.27 | $63.73K | 1.9% | 627.10K | 639.20K |
| Total | +12.10K | $63.73K | ||||||
Derivative Transactions0
No derivative transactions reported